Health Policy in China
This project was completed in 2019. For more information about related, current Duke-Margolis work, please visit our website or contact us at healthpolicy@duke.edu.
Overview
The Duke-Margolis team has engaged with key health system leaders from China to advance journey towards care delivery and payment reform.
See specific projects below
Health delivery and payment transformation in China
The Center is involved in several initiative to support care transformation and improvements in China’s health care delivery and payment systems. The Center is helping lead an ongoing bilateral discussion hosted by the National Committee on US-China Relations to identify potential paths for accelerating care transformation in both countries. The Center has also explored projects in care and health delivery reforms with a range of partners, including the World Bank, the National Health Security Administration (NHSA), and the Chinese Academy of Social Sciences.
Medical product regulatory reform in China
The Center has engaged with the National Medical Product Administration to help bring clinical trials and evidentiary standards in-line with international best practices.
Publication(s)
1. NCUSR, U.S.-CHINA TRACK II DIALOGUE ON HEALTHCARE 2018 REPORT
2. NCUSR, U.S.-CHINA TRACK II DIALOGUE ON HEALTHCARE 2019 REPORT
Duke-Margolis Team
Mark McClellan, MD, PhD
Director of the Duke-Margolis Institute for Health Policy
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty
Aparna Higgins
Senior Policy Advisor
